PEPFAR Scale-up of Pediatric HIV Services
- 15 August 2012
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 60 (Supplement) , S105-S112
Abstract
HIV/AIDS has had a profound impact on children around the world since the start of the epidemic. There are currently 3.4 million children under the age of 15 years living with HIV globally, and more than 450,000 children currently receiving lifesaving antiretroviral treatment. This article describes efforts supported by the President's Emergency Plan for AIDS Relief (PEPFAR) to expand access to treatment for children living with HIV in high-burden countries. The article also highlights a series of case studies that illustrate the impact that the PEPFAR initiative has had on the pediatric HIV epidemic. Through its support of host governments and partner organizations, the PEPFAR initiative has expanded HIV testing and treatment for pregnant women to reduce vertical transmission of HIV, increased access to early infant diagnosis for HIV-exposed infants, improved training and resources for clinicians who provide pediatric care and antiretroviral treatment, and, through public–private partnerships with pharmaceutical manufacturers, helped increase the number of medications available for the treatment of HIV-infected children in resource-limited settings.Keywords
This publication has 45 references indexed in Scilit:
- Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South AfricaBMC Infectious Diseases, 2012
- Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatmentAIDS, 2011
- Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventionsBMC Medicine, 2011
- The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in childrenBMC Pediatrics, 2010
- Initial Response to Protease‐Inhibitor‐Based Antiretroviral Therapy among Children Less than 2 Years of Age in South Africa: Effect of Cotreatment for TuberculosisThe Journal of Infectious Diseases, 2010
- Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected childrenMalaria Journal, 2009
- Successful paediatric HIV treatment in rural primary care in AfricaArchives of Disease in Childhood, 2009
- Early Antiretroviral Therapy and Mortality among HIV-Infected InfantsNew England Journal of Medicine, 2008
- Clinical presentation and outcome of Tuberculosis in Human Immunodeficiency Virus infected children on anti-retroviral therapyBMC Pediatrics, 2008
- The effect of HIV on morbidity and mortality in children with severe malarial anaemiaMalaria Journal, 2007